Search results
Shark Tank India's Namita Thapar to make a whopping amount of around Rs 127cr from her brand's IPO...
The Times of India· 5 days agoShark Tank India's Namita Thapar is to receive a whopping of around Rs 127 cr from her recent...
Meet Namita Thapar, Shark Tank Judge Who is Raking in Nearly Rs 128 Crore via Emcure Pharma IPO -...
News18· 4 days agoNamita Thapar is a remarkably successful businesswoman who is also an investor on Shark Tank India...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 5 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 6 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 7 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on ...
Who Is Namita Thapar, Shark Tank Judge Set To Earn Rs 127 Crore From IPO
NDTV· 5 days agoEntrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in...
Emcure has better listed pharma alternatives
The Economic Times· 5 days agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical ...
Namita Thapar may gain ₹127 crore in Emcure Pharma IPO
Hindustan Times· 7 days agoThrough the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 6 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 5 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...